RU2011148536A - METHOD FOR INTEGRATED TREATMENT OF ACUTE INTESTINAL OBSTACLES OF CARCINOMATOSIS GENESIS - Google Patents
METHOD FOR INTEGRATED TREATMENT OF ACUTE INTESTINAL OBSTACLES OF CARCINOMATOSIS GENESIS Download PDFInfo
- Publication number
- RU2011148536A RU2011148536A RU2011148536/15A RU2011148536A RU2011148536A RU 2011148536 A RU2011148536 A RU 2011148536A RU 2011148536/15 A RU2011148536/15 A RU 2011148536/15A RU 2011148536 A RU2011148536 A RU 2011148536A RU 2011148536 A RU2011148536 A RU 2011148536A
- Authority
- RU
- Russia
- Prior art keywords
- day
- carcinomatosis
- acute intestinal
- perform
- infusion therapy
- Prior art date
Links
- 201000009030 Carcinoma Diseases 0.000 title claims abstract 3
- 230000001154 acute effect Effects 0.000 title claims abstract 3
- 206010061289 metastatic neoplasm Diseases 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title claims abstract 3
- 230000000968 intestinal effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 6
- 238000001802 infusion Methods 0.000 claims abstract 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract 4
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 claims abstract 2
- 241000792859 Enema Species 0.000 claims abstract 2
- JPXZQMKKFWMMGK-KQYNXXCUSA-K IDP(3-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])([O-])=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 JPXZQMKKFWMMGK-KQYNXXCUSA-K 0.000 claims abstract 2
- 108010016076 Octreotide Proteins 0.000 claims abstract 2
- 230000003474 anti-emetic effect Effects 0.000 claims abstract 2
- 230000002921 anti-spasmodic effect Effects 0.000 claims abstract 2
- 239000002111 antiemetic agent Substances 0.000 claims abstract 2
- 229940125683 antiemetic agent Drugs 0.000 claims abstract 2
- 229940124575 antispasmodic agent Drugs 0.000 claims abstract 2
- 230000006837 decompression Effects 0.000 claims abstract 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims abstract 2
- 229960003957 dexamethasone Drugs 0.000 claims abstract 2
- 239000007920 enema Substances 0.000 claims abstract 2
- 229940079360 enema for constipation Drugs 0.000 claims abstract 2
- 208000003243 intestinal obstruction Diseases 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- 229960002700 octreotide Drugs 0.000 claims abstract 2
- 206010034674 peritonitis Diseases 0.000 claims abstract 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract 2
- 210000002784 stomach Anatomy 0.000 claims abstract 2
- 238000001356 surgical procedure Methods 0.000 claims abstract 2
- 208000024891 symptom Diseases 0.000 claims abstract 2
- 239000011726 vitamin B6 Substances 0.000 claims abstract 2
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract 2
- 229940011671 vitamin b6 Drugs 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ комплексного лечения острой кишечной непроходимости карциноматозного генеза путем раннего проведения инфузионной терапии с антиэметиками и спазмолитиками, отличающийся тем, что в состав инфузионной терапии дополнительно входят: дексаметазон - 0,1 мг/кг в сутки, октреотид - 100 мкг 3 раза в сутки, ортофен - 75 мг 2 раза в сутки, цитофлавин - 0,5 мл/кг в/в в сутки, рибоксин - 20 мл в/в в сутки, витамин В6 - 4 мл в/в в сутки, и одновременно проводят длительную декомпрессию желудка, выполняют сакроспинальные блокады, очистительные или сифонные клизмы, а при неэффективности консервативной терапии, проводимой в течение 3 суток, при отсутствии положительной динамики по данным, при появлении клинических симптомов перитонита выполняют оперативное вмешательство.A method for the complex treatment of acute intestinal obstruction of carcinomatosis by early infusion therapy with antiemetics and antispasmodics, characterized in that the composition of the infusion therapy additionally includes: dexamethasone - 0.1 mg / kg per day, octreotide - 100 μg 3 times a day, orthophene - 75 mg 2 times a day, cytoflavin - 0.5 ml / kg iv / day, riboxin - 20 ml iv / day, vitamin B6 - 4 ml iv / day, and at the same time carry out a long decompression of the stomach, perform sacrospinal blockade, cleansing or siphon enemas, after failure of conservative therapy carried out for 3 days, in the absence of positive dynamic data, the appearance of clinical symptoms of peritonitis perform surgery.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011148536/15A RU2011148536A (en) | 2011-11-29 | 2011-11-29 | METHOD FOR INTEGRATED TREATMENT OF ACUTE INTESTINAL OBSTACLES OF CARCINOMATOSIS GENESIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011148536/15A RU2011148536A (en) | 2011-11-29 | 2011-11-29 | METHOD FOR INTEGRATED TREATMENT OF ACUTE INTESTINAL OBSTACLES OF CARCINOMATOSIS GENESIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011148536A true RU2011148536A (en) | 2013-11-20 |
Family
ID=49554757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011148536/15A RU2011148536A (en) | 2011-11-29 | 2011-11-29 | METHOD FOR INTEGRATED TREATMENT OF ACUTE INTESTINAL OBSTACLES OF CARCINOMATOSIS GENESIS |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2011148536A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412139A (en) * | 2015-12-04 | 2016-03-23 | 中国人民解放军海军医学研究所 | Application of inosine in preparing medicine for preventing decompression sickness caused by fast buoyancy ascent escape |
-
2011
- 2011-11-29 RU RU2011148536/15A patent/RU2011148536A/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412139A (en) * | 2015-12-04 | 2016-03-23 | 中国人民解放军海军医学研究所 | Application of inosine in preparing medicine for preventing decompression sickness caused by fast buoyancy ascent escape |
| CN105412139B (en) * | 2015-12-04 | 2018-01-16 | 中国人民解放军海军医学研究所 | Application of the inosine in preparing prevention quick upward floating danger-removal and causing the medicine of decompression sickness |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201001771A1 (en) | RELAXIN TREATMENT TREATMENT ASSOCIATED WITH ACUTE HEALTH INSUFFICIENCY | |
| EA201100778A1 (en) | HETEROCYCLIC SUBSTITUTED COMPOUNDS AS HIF INHIBITORS | |
| EA201170669A1 (en) | TREATMENT OF PYRPHENIDONE PATIENTS WITH ATYPICAL LIVER FUNCTION | |
| MX353482B (en) | METHODS FOR THE TREATMENT OF CANCER and INFLAMMATORY DISEASES USING CEREBLON AS A PREDICTOR. | |
| EA201301354A1 (en) | SGLT-2 INHIBITORS DESIGNED FOR THE TREATMENT OF METABOLIC DISORDERS IN PATIENTS TREATED BY NEUROLEPTICS | |
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| EA201270071A1 (en) | A METHOD OF TREATING A PATIENT NEEDING ASPIRIN TREATMENT | |
| AR086422A1 (en) | METHOD FOR THE TREATMENT OF ADVANCED SOLID TUMORS, VOLASERTIB | |
| ATE460940T1 (en) | IRON(III) COMPLEX COMPOUNDS FOR THE ORAL TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE | |
| RU2011148536A (en) | METHOD FOR INTEGRATED TREATMENT OF ACUTE INTESTINAL OBSTACLES OF CARCINOMATOSIS GENESIS | |
| MX2011009804A (en) | A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment. | |
| PE20130308A1 (en) | METHODS TO TREAT RECURRING BACTERIAL INFECTIONS | |
| WO2011072181A3 (en) | Method of treating pancreatic cancer | |
| RU2009105344A (en) | METHOD FOR TREATMENT OF INFLAMMATORY CHORIORETHINAL DYSTROPHIES | |
| CY1119845T1 (en) | A MILK PRODUCT OF REDUCED CHOLESTEROL FOR USE IN THERAPEUTIC TREATMENT AND / OR PREVENTION OF A US DISEASE | |
| RU2010142165A (en) | METHOD FOR INTEGRATED TREATMENT OF ACUTE PULMONARY ARBOLIA | |
| RU2008130241A (en) | METHOD AND MEANS FOR REHABILITATION OF CHILDREN WITH CHRONIC RHINOSINUSITES | |
| RU2011124639A (en) | METHOD FOR TREATING PURULO-SEPTIC COMPLICATIONS IN PROSTATE Adenoma | |
| UA59667U (en) | method for medical rehabilitation of patients with nonalcoholic steatohepatitis using antihomotoxic treatment agents | |
| UA114660U (en) | METHOD OF COMPLEX TREATMENT OF PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE WITH STEATOGEPATITIS | |
| RU2007140029A (en) | METHOD FOR TREATING CHRONIC HEART FAILURE | |
| UA75872U (en) | Method for rehabilitation of patients with ischemic heart disease in combination with diabetes mellitus type 2 | |
| RU2009124997A (en) | METHOD FOR TUBERCULOSE CHORIORETHINITIS TREATMENT | |
| WO2012075211A3 (en) | Combination therapy with a gallium complex | |
| UA71208U (en) | method for treatment of mild artearial hypertensy in patients with abdomynal obesity |